Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects

Neuropharmacology. 1994 Mar-Apr;33(3-4):457-65. doi: 10.1016/0028-3908(94)90076-0.

Abstract

1-(3-Chlorophenyl)piperazine (mCPP) (0.125-1.0 mg/kg i.p.), previously shown to inhibit social interaction, dose-dependently reduced exploration of the open arms of an elevated plus-maze. These findings suggest anxiogenic properties. The effect of mCPP was more potently inhibited by 1-(1-naphthyl)piperazine than by ketanserin, indicative of its mediation via activation of 5-HT2C rather than 5-HT2A receptors. The 5-HT1B receptor agonist CGS 12066B did not antagonise the anxiety-like response to mCPP, and further reduced exploration at the highest dose tested (10 mg/kg i.p.). Depletion of serotonin (5-HT) by p-chlorophenylalanine (PCPA, 150 mg/kg/day x 3) did not prevent the response, although PCPA itself increased open arm exploration. The 5-HT1A/B and beta-adrenoceptor antagonist 1-propanolol (5 mg/kg i.p.) and the peripheral beta 1-receptor antagonist atenolol (20 mg/kg i.p.) showed no significant activity on the plus-maze either alone or against the anxiogenic effect of mCPP. These results indicate that mCPP induces anxiety in the rat in the elevated plus-maze primarily by stimulation of postsynaptic 5-HT2C receptors, and suggest that sympathomimetic effects of mCPP are not involved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Animals
  • Anxiety / chemically induced*
  • Fenclonine / pharmacology
  • Male
  • Piperazines / antagonists & inhibitors
  • Piperazines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta / drug effects
  • Receptors, Serotonin / drug effects*
  • Serotonin Receptor Agonists / pharmacology*
  • Sympathomimetics / pharmacology*
  • Synapses / physiology

Substances

  • Adrenergic beta-Antagonists
  • Piperazines
  • Receptors, Adrenergic, beta
  • Receptors, Serotonin
  • Serotonin Receptor Agonists
  • Sympathomimetics
  • 1-(1-naphthyl)piperazine
  • Fenclonine
  • 1-(3-chlorophenyl)piperazine